NO128403B - - Google Patents
Download PDFInfo
- Publication number
- NO128403B NO128403B NO69471A NO69471A NO128403B NO 128403 B NO128403 B NO 128403B NO 69471 A NO69471 A NO 69471A NO 69471 A NO69471 A NO 69471A NO 128403 B NO128403 B NO 128403B
- Authority
- NO
- Norway
- Prior art keywords
- formula
- same meaning
- derivative
- stated above
- indolyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 28
- 239000002253 acid Substances 0.000 claims description 25
- -1 3-indolyl aliphatic aldehyde Chemical class 0.000 claims description 24
- 150000004031 phenylhydrazines Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- MBBOMCVGYCRMEA-UHFFFAOYSA-N tryptophol Chemical class C1=CC=C2C(CCO)=CNC2=C1 MBBOMCVGYCRMEA-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000002541 furyl group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 238000002844 melting Methods 0.000 description 32
- 230000008018 melting Effects 0.000 description 32
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 6
- 238000004452 microanalysis Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 229960002895 phenylbutazone Drugs 0.000 description 4
- 239000012286 potassium permanganate Substances 0.000 description 4
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 229940054051 antipsychotic indole derivative Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- NKPPORKKCMYYTO-DHZHZOJOSA-N cinmetacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)\C=C\C1=CC=CC=C1 NKPPORKKCMYYTO-DHZHZOJOSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- XEZFXHXFDSKABN-UHFFFAOYSA-N 2-[5-methoxy-2-methyl-1-(2-phenylacetyl)indol-3-yl]acetic acid Chemical compound C1(=CC=CC=C1)CC(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C XEZFXHXFDSKABN-UHFFFAOYSA-N 0.000 description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 2
- 239000005750 Copper hydroxide Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910001956 copper hydroxide Inorganic materials 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 150000002475 indoles Chemical class 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KGWJFPQDJFWKFP-UHFFFAOYSA-N 2-[5-methoxy-2-methyl-1-(2-phenylbutanoyl)indol-3-yl]acetic acid Chemical compound CCC(C(=O)N1C(C)=C(CC(O)=O)C2=CC(OC)=CC=C12)C1=CC=CC=C1 KGWJFPQDJFWKFP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- MXZFUWSCIYTBKO-UHFFFAOYSA-N C1(=CC=CC2=CC=CC=C12)CC(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C Chemical compound C1(=CC=CC2=CC=CC=C12)CC(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C MXZFUWSCIYTBKO-UHFFFAOYSA-N 0.000 description 1
- ADSGPHJZLIGNHU-UHFFFAOYSA-N COC1=CC=C(C=C1)N(C(C(CC(=O)O)=O)C)C(CC1=CC=CC=C1)=O Chemical compound COC1=CC=C(C=C1)N(C(C(CC(=O)O)=O)C)C(CC1=CC=CC=C1)=O ADSGPHJZLIGNHU-UHFFFAOYSA-N 0.000 description 1
- NULVYUKTWSEFPY-UHFFFAOYSA-N COC1=CC=C(C=CC(=O)N2C(=C(C3=CC(=CC=C23)OC)CC(=O)O)C)C=C1 Chemical compound COC1=CC=C(C=CC(=O)N2C(=C(C3=CC(=CC=C23)OC)CC(=O)O)C)C=C1 NULVYUKTWSEFPY-UHFFFAOYSA-N 0.000 description 1
- XENJFXWLUDNTSF-UHFFFAOYSA-N ClC1=CC=C(C=C1)CC(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C Chemical compound ClC1=CC=C(C=C1)CC(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C XENJFXWLUDNTSF-UHFFFAOYSA-N 0.000 description 1
- KQCIWIHKWHLFMB-UHFFFAOYSA-N ClC1=CC=C(C=CC(=O)N2C(=C(C3=CC(=CC=C23)OC)CC(=O)O)C)C=C1 Chemical compound ClC1=CC=C(C=CC(=O)N2C(=C(C3=CC(=CC=C23)OC)CC(=O)O)C)C=C1 KQCIWIHKWHLFMB-UHFFFAOYSA-N 0.000 description 1
- 238000006641 Fischer synthesis reaction Methods 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical group CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- WEMJCDDYUBVWRB-UHFFFAOYSA-N n-(4-methoxyphenyl)-3-phenylprop-2-enamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C=CC1=CC=CC=C1 WEMJCDDYUBVWRB-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229960000649 oxyphenbutazone Drugs 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 238000011046 pyrogen test Methods 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical group CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO69471A NO128403B (cg-RX-API-DMAC7.html) | 1966-01-12 | 1971-02-24 |
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP199966 | 1966-01-12 | ||
| JP2730166 | 1966-04-28 | ||
| JP2730066 | 1966-04-28 | ||
| JP2812566 | 1966-05-02 | ||
| JP2840066 | 1966-05-04 | ||
| JP3030666 | 1966-05-12 | ||
| JP4059166 | 1966-06-21 | ||
| JP4472466 | 1966-07-08 | ||
| JP4472366 | 1966-07-08 | ||
| JP5467566 | 1966-08-19 | ||
| JP5467466 | 1966-08-19 | ||
| JP8248066 | 1966-12-15 | ||
| JP8264966 | 1966-12-16 | ||
| JP8265066 | 1966-12-16 | ||
| JP8374866 | 1966-12-20 | ||
| JP135267 | 1967-01-06 | ||
| NO16809967A NO128402B (cg-RX-API-DMAC7.html) | 1966-01-12 | 1967-05-11 | |
| NO69471A NO128403B (cg-RX-API-DMAC7.html) | 1966-01-12 | 1971-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO128403B true NO128403B (cg-RX-API-DMAC7.html) | 1973-11-12 |
Family
ID=27586091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO69471A NO128403B (cg-RX-API-DMAC7.html) | 1966-01-12 | 1971-02-24 |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO128403B (cg-RX-API-DMAC7.html) |
-
1971
- 1971-02-24 NO NO69471A patent/NO128403B/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3275644A (en) | Certain 1-azolylindol-3-ylaliphatic acids | |
| US4146721A (en) | Pyrazol-4-acetic acid compounds | |
| US3629284A (en) | Process for the preparation of 3-indolyl aliphatic acid derivatives | |
| US3336194A (en) | Indolyl acid amides | |
| JPS5839673A (ja) | 置換されたピペラジン―２―オン | |
| NO162587B (no) | Anordning for aa overvaake tilstedevaerelsen av en person i en seng. | |
| US3489767A (en) | 1-(phenylsulfonyl)-3-indolyl aliphatic acid derivatives | |
| JPH0629270B2 (ja) | Ｎ―置換２―アミノチアゾール類及び治療用組成物 | |
| US3271394A (en) | Alpha-indolyl-3-acetic acid esters | |
| US3515728A (en) | Semicarbazone and thiosemicarbazone derivatives of 5-nitroimidazoles | |
| US3470203A (en) | Intermediates for preparing 1-aroylindole-3-alkanoic acids | |
| US3365447A (en) | 2, 5-dihydro-4-hydroxy-2-oxothiophens | |
| US3544563A (en) | Certain 3-indolyl-lower-alkanoic acid derivatives | |
| NO128403B (cg-RX-API-DMAC7.html) | ||
| US4673692A (en) | Diphenylmethylimine derivatives, their compositions and pharmaceutical uses | |
| US3576800A (en) | 1-acyl-3-indolyl aliphatic acid derivatives and their method of preparation | |
| US4116972A (en) | Anti-inflammatory 1-oxo-isoindoline derivatives and processes for their preparation | |
| US3564008A (en) | Process for preparing 1-acyl-2-phenyl-3-indolylaliphatic acid derivatives | |
| US3510495A (en) | Novel substituted 1-amino-2-pyrrolidinones | |
| SU415880A3 (ru) | Способ получения производных бензодиазепина | |
| US3551446A (en) | 1-aryloxyalkylcarbonyl-3-indolyl aliphatic acid derivatives | |
| US3573290A (en) | Substituted cinnamic acids | |
| US4060550A (en) | Novel n'-acylated phenyl-hydrazine and -hydrazone derivatives | |
| US3564011A (en) | Method for preparing 1-acyl-3-indolyl aliphatic acid derivatives | |
| FI81782C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-styrensulfonyl-2-oxo-5-hydroxi-pyrrolidinderivat. |